eXoZymes CEO to Discuss Commercialization, Key Milestones, and Potential Catalysts in Fireside Chat with Water Tower ResearchAccesswire · 3 days ago
Water Tower Research Publishes Initiation of Coverage Report on eXoZymes, Inc., "Converting Cell-Free Science into a Scalable and Repeatable Commercial Opportunity"TheNewswire · Oct 2, 2026
Head to Head Contrast: Iovance Biotherapeutics (NASDAQ:IOVA) vs. eXoZymes (NASDAQ:EXOZ)Defense World · Sep 17, 2026
eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCTAccesswire · Sep 8, 2026
eXoZymes Q2 Earnings Call HighlightsDefense World · Aug 22, 2026
eXoZymes Q2 Earnings Call HighlightsMarketBeat · Aug 20, 2026eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.